Home > Drug Search >
  • Targets: Glutamyl aminopeptidase (ENPEP)
  •   > 
Drug Filter
Category:
chemistry (37) biology (1)
Status:
Approved (8) Withdrawn (1) NDA Filing (1) Phase Ⅲ (2) Phase Ⅱ (15) Phase Ⅰ (11)
Clinical Stage:
Pending (11) Active (9) Discontinued (9)
Company:
Endo (1) Genzyme (2) Gilead (1) GlaxoSmithKline (1) Ionis Pharmaceuticals (1) Lilly (1) Lundbeck (2) MedImmune (1) Motif Bio (1) Dana-Farber Cancer Institute (1) Pfizer (1) Roche (2) Spectrum Pharmaceuticals (1) Takeda (1) Apeiron Biologics (1) Unknown (3) Polymun Scientific (1) Ash Stevens (1) Shin Poong Pharmaceutical (1) Virbac (1) Astex Pharmaceuticals (1) ActivBiotics (1) Ardelyx (1) Quantum Genomic (1) Syntrix Biosystems (1) Roswell Park Cancer Institute (1) Aeolus Pharmaceuticals (1) Novogen (1) Ability Pharm (1) Galera (3) Antares Pharma (1) EGIS (1) Tufts University (1) Turing Pharmaceuticals (1) MetaPhore Pharmaceuticals (1) Auspex (1) Ludwig Institute for Cancer Research (1) Achaogen (1) AstraZeneca (1) BioNumerik (1) Chugai (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Acute lymphoblastic leukaemia (ALL) (3) Acute otitis media (1) Amyotrophic lateral sclerosis (ALS) (1) Bladder cancer (1) Breast cancer (1) Cancer chemotherapy (1) Cancer related pain (1) Crohn's disease (1) Susceptible protozoal infections (1) Endometrial cancer (1) HIV infection (2) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Inflammatory bowel disease (1) Irritable bowel syndrome with constipation (IBS-C) (1) Lung cancer (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin B-cell lymphomas (1) Osteosarcoma (1) Peripheral T cell lymphoma (PTCL) (1) Pleural mesothelioma (1) Pneumonia (3) Postoperative pain (1) Psoriasis (1) Peyronie's disease (1) Rheumatoid arthritis (RA) (5) Solid tumours (4) Ulcerative colitis (1) Urinary tract infections (1) Radiodermatitis (1) Pneumocystis pneumonia (1) Pain (1) Stroke (1) Relapsed or refractory malignant lymphoma (1) Malaria (1) Kaposi's sarcoma (1) Hyperphosphatemia (1) Oral mucositis (1) Gram-negative bacterial infection (1) Pulmonary fibrosis (1) Bacterial infection (3) Stomatitis (2)
Aprv. Year:
2004 (1) 2009 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top